Bio-Techne (TECH) Research & Development (2009 - 2026)
Bio-Techne (TECH) posted quarterly Research & Development of $23.5 million for Q1 2026, down 4.57% year-over-year from $24.6 million in Q1 2025, and up 1.43% quarter-over-quarter from $23.1 million in Q4 2025.
Bio-Techne (TECH) Research & Development (2009 - 2026) Analysis & Trends
Bio-Techne's Research & Development history runs 18 years deep, the most recent figure standing at $23.5 million for Q1 2026.
- In Q1 2026, Research & Development fell 4.57% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $96.9 million (down 0.62% YoY), while the FY2025 annual figure was $99.5 million, up 2.93% from the prior year.
- Research & Development for Q1 2026 stood at $23.5 million, up from $23.1 million in the prior quarter.
- The five-year high for Research & Development was $26.0 million in Q2 2025, with the low at $21.7 million in Q1 2022.
- The 5-year median for Research & Development is $23.9 million (2024), against an average of $23.8 million.
- The sharpest annual moves came in 2022 and 2025: Research & Development advanced 27.5% in 2022, then dropped 7.56% in 2025.
- Bio-Techne's Research & Development stood at $22.5 million in 2022, then climbed by 2.03% to $22.9 million in 2023, then climbed by 9.16% to $25.0 million in 2024, then decreased by 7.56% to $23.1 million in 2025, then grew by 1.43% to $23.5 million in 2026.
- Business Quant data shows TECH's Research & Development at $23.5 million in Q1 2026, $23.1 million in Q4 2025, and $24.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 23.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.46 Mn |
| Dec 31, 2025 | 23.13 Mn |
| Sep 30, 2025 | 24.24 Mn |
| Jun 30, 2025 | 26.03 Mn |
| Mar 31, 2025 | 24.58 Mn |
| Dec 31, 2024 | 25.02 Mn |
| Sep 30, 2024 | 23.87 Mn |
| Jun 30, 2024 | 23.99 Mn |
| Mar 31, 2024 | 25.76 Mn |
| Dec 31, 2023 | 22.92 Mn |
| Sep 30, 2023 | 24.00 Mn |
| Jun 30, 2023 | 23.42 Mn |
| Mar 31, 2023 | 22.71 Mn |
| Dec 31, 2022 | 22.46 Mn |
| Sep 30, 2022 | 23.90 Mn |
| Jun 30, 2022 | 23.15 Mn |
| Mar 31, 2022 | 21.74 Mn |
| Dec 31, 2021 | 20.65 Mn |
| Sep 30, 2021 | 21.60 Mn |
| Jun 30, 2021 | 20.72 Mn |